LOS ANGELES, April 9 (Reuters) - Billionaire investor Carl Icahn on Thursday joined a lawsuit against Amylin Pharmaceuticals Inc (AMLN.O) seeking to invalidate debt acceleration provisions that would be triggered in the event of a change in control of the company’s board.
